Description: Genetic Technologies Limited provides genetic testing services. It offers a range of DNA based genetic tests for cancer predisposition, including breast cancer, ovarian cancer, bowel cancer, and uterine cancer; neurogenetic diagnostic assays; and gene testing for gene related disorders. The company also provides forensics tests, such as presumptive and confirmatory testing, individual DNA profiling, species identification, and animal forensic testing; paternity tests, which include antenatal, deceased estate, grandparent, immigration, legal paternity, non-legal paternity, sibling, twins, and Y-Chromosome DNA testing, as well as DNA profiling; and personal DNA testing comprising sports performance and ancestry gene testing. In addition, it offers animals' tests consisting of disease testing, breed identification, coat color, and forensic DNA testing, as well as DNA clinical services; and plant tests, including genomic and Xpress sequencing services. Further, the company is involved in the out-licensing of its intellectual property relating to non-coding DNA; and research and development activities in the areas of genetics and related fields. It operates in Australia, the United States, China, Canada, and Switzerland. The company was formerly known as Duketon Goldfields N.L. and changed it name to Genetic Technologies Limited in August 2000 as a result of the change in business from mining to biotechnology. Genetic Technologies Limited is headquartered in Fitzroy, Australia.
Home Page: genetype.com
GENE Technical Analysis
60-66 Hanover Street
Fitzroy,
VIC
3065
Australia
Phone:
61 3 8412 7000
Officers
Name | Title |
---|---|
Mr. Simon Morriss | Chief Exec. Officer |
Dr. Richard Allman Ph.D. | Chief Scientific Officer |
Mr. Carl S. Stubbings BSc | Chief Commercial Officer |
Mr. Tony Di Pietro AGIA, B.Com, C.A., CPA, M.A.I.C.D. | CFO & Company Sec. |
Mr. Paul Keith Mathieson Viney B. Bus, FCI, FCPA, FGIA | Consultant |
Mr. Kevin Camilleri | Chief Exec. Officer of EasyDNA |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Life Sciences Tools & Services |
GIC Sub-Industry: | Life Sciences Tools & Services |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 1.6034 |
Price-to-Sales TTM: | 2.0411 |
IPO Date: | 2005-09-02 |
Fiscal Year End: | June |
Full Time Employees: | 52 |